Paper II
2022 July (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

Corticosteroids.

Q58 marksShort Essays

Answer

Classification (by glucocorticoid:mineralocorticoid potency ratio)

GroupExamples
Short-acting, high mineralocorticoid activityHydrocortisone, Cortisone
Intermediate-acting, minimal mineralocorticoid activityPrednisolone, Methylprednisolone
Long-acting, negligible mineralocorticoid activityDexamethasone, Betamethasone
Pure mineralocorticoidFludrocortisone

Mechanism of action Corticosteroids diffuse across the cell membrane and bind cytoplasmic glucocorticoid receptors; the activated complex translocates to the nucleus and alters gene transcription — a genomic mechanism explaining the characteristically delayed onset of anti-inflammatory action. Key downstream effects: induction of lipocortin-1, which inhibits phospholipase A2 and cuts off the entire eicosanoid cascade (prostaglandins and leukotrienes) at its source; suppression of pro-inflammatory cytokine gene transcription (IL-1, IL-2, IL-6, TNF-alpha); reduced leukocyte migration/adhesion; and lymphocyte redistribution/suppression underlying the immunosuppressive effect.

Therapeutic uses

  • Replacement therapy — Addison’s disease
  • Anti-inflammatory/immunosuppressive use — rheumatoid arthritis, SLE
  • Allergic emergencies — anaphylaxis, angioedema, severe asthma
  • Organ transplant rejection prophylaxis
  • Cerebral edema (dexamethasone, minimal mineralocorticoid effect avoids counterproductive fluid retention)
  • Nephrotic syndrome
  • Antenatal fetal lung maturation in threatened preterm labour

Adverse effects

  • Cushingoid features, hyperglycemia (insulin-antagonist metabolic effect), osteoporosis
  • Peptic ulceration, increased susceptibility to infection
  • Hypertension, growth retardation in children, cataract/glaucoma
  • Adrenal suppression — risk of adrenal crisis on abrupt withdrawal, requiring tapering after prolonged use
  • Psychiatric disturbances, myopathy

Other Years Asked


Revise MBBS
Preview